Iminosugars as potential inhibitors of glycogenolysis: Structural insights into the molecular basis of glycogen phosphorylase inhibition

被引:59
作者
Oikonomakos, Nikos G.
Tiraidis, Costas
Leonidas, Demetres D.
Zographos, Spyros E.
Kristiansen, Marit
Jessen, Claus U.
Norskov-Lauritsen, Leif
Agius, Loranne
机构
[1] Natl Hellen Res Fdn, Inst Organ & Pharmaceut Chem, Athens 11635, Greece
[2] Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens 11635, Greece
[3] Novo Nordisk AS, DK-2760 Malov, Denmark
[4] Med Sch Newcastle Upon Tyne, Sch Clin Med Sci, Div Diabet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
D O I
10.1021/jm060496g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Iminosugars DAB (5), isofagomine (9), and several N-substituted derivatives have been identified as potent inhibitors of liver glycogen phosphorylase a (IC50 = 0.4-1.2 mu M) and of basal and glucagon-stimulated glycogenolysis (IC50 = 1-3 mu M). The X-ray structures of 5, 9, and its N-3-phenylpropyl analogue 8 in complex with rabbit muscle glycogen phosphorylase (GPb) shows that iminosugars bind tightly at the catalytic site in the presence of the substrate phosphate and induce conformational changes that characterize the R-state conformation of the enzyme. Charged nitrogen N1 is within hydrogen-bonding distance with the carbonyl oxygen of His377 (5) and in ionic contact with the substrate phosphate oxygen (8 and 9). Our findings suggest that the inhibitors function as oxocarbenium ion transition-state analogues. The conformational change to the R state provides an explanation for previous findings that 5, unlike inhibitors that favor the T state, promotes phosphorylation of GPb in hepatocytes with sequential inactivation of glycogen synthase.
引用
收藏
页码:5687 / 5701
页数:15
相关论文
共 84 条
  • [51] Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo
    Martin, WH
    Hoover, DJ
    Armento, SJ
    Stock, IA
    McPherson, RK
    Danley, DE
    Stevenson, RW
    Barrett, EJ
    Treadway, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) : 1776 - 1781
  • [52] Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy
    McCormack, JG
    Westergaard, N
    Kristiansen, M
    Brand, CL
    Lau, J
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (14) : 1451 - 1474
  • [53] SUBSTRATE COFACTOR INTERACTIONS FOR GLYCOGEN PHOSPHORYLASE-B - A BINDING STUDY IN THE CRYSTAL WITH HEPTENITOL AND HEPTULOSE 2-PHOSPHATE
    MCLAUGHLIN, PJ
    STUART, DI
    KLEIN, HW
    OIKONOMAKOS, NG
    JOHNSON, LN
    [J]. BIOCHEMISTRY, 1984, 23 (24) : 5862 - 5873
  • [54] Raster3D: Photorealistic molecular graphics
    Merritt, EA
    Bacon, DJ
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 : 505 - 524
  • [55] Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states
    Mitchell, EP
    Withers, SG
    Ermert, P
    Vasella, AT
    Garman, EF
    Oikonomakos, NG
    Johnson, LN
    [J]. BIOCHEMISTRY, 1996, 35 (23) : 7341 - 7355
  • [56] Refinement of macromolecular structures by the maximum-likelihood method
    Murshudov, GN
    Vagin, AA
    Dodson, EJ
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1997, 53 : 240 - 255
  • [57] THE FAMILY OF GLYCOGEN PHOSPHORYLASES - STRUCTURE AND FUNCTION
    NEWGARD, CB
    HWANG, PK
    FLETTERICK, RJ
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 24 (01) : 69 - 99
  • [58] Detailed structural analysis of glycosidase/inhibitor interactions:: Complexes of Cex from Cellulomonas fimi with xylobiose-derived aza-sugars
    Notenboom, V
    Williams, SJ
    Hoos, R
    Withers, SG
    Rose, DR
    [J]. BIOCHEMISTRY, 2000, 39 (38) : 11553 - 11563
  • [59] The crystal structure of the Escherichia coli maltodextrin phosphorylase-acarbose complex
    O'Reilly, M
    Watson, KA
    Johnson, LN
    [J]. BIOCHEMISTRY, 1999, 38 (17) : 5337 - 5345
  • [60] Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors
    Ogawa, AK
    Willoughby, CA
    Bergeron, R
    Ellsworth, KP
    Geissler, WM
    Myers, RW
    Yao, J
    Harris, G
    Chapman, KT
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) : 3405 - 3408